DailyStocks Stock Article Search

https://www.zacks.com/stock/news/2212223/sana-bio-sana-stock-rallies-105-in-3-months-here-s-why?cid=CS-ZC-FT-analyst_blog|price_surge_/_plunge-2212223 Jan 18, 2024 - Sana Bio (SANA) rallies 105% after the company reports encouraging pipeline progress with its candidates, SC291 and SC262, for oncology and autoimmune indications. 0

https://seekingalpha.com/news/4055774-instil-bio-stock-hits-four-month-high?source=feed_sector_healthcare Jan 17, 2024 - Instil Bio (TIL) stock surged 21% on Wednesday after the biotech announced cost-cutting measures and a new partnership for its ITIL-306 program. Read more here. 0

https://www.zacks.com/stock/news/2210645/igm-bio-igms-stock-rallies-142-in-3-months-here-s-why?cid=CS-ZC-FT-analyst_blog|price_surge_/_plunge-2210645 Jan 16, 2024 - IGM Bio (IGMS) stock surges 142% in the past three months on strategic reprioritization efforts to focus its resources on the development of pipeline candidates for cancer and autoimmune indications. 0

https://www.zacks.com/stock/news/2209668/all-you-need-to-know-about-2seventy-bio-inc-tsvt-rating-upgrade-to-strong-buy?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_12_zacks_rank_upgrade-2209668 Jan 12, 2024 - 2seventy bio, Inc. (TSVT) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term. 0

https://www.zacks.com/stock/news/2209477/down-11-17-in-4-weeks-here-s-why-theravance-bio-tbph-looks-ripe-for-a-turnaround?cid=CS-ZC-FT-tale_of_the_tape|rsi-2209477 Jan 12, 2024 - The heavy selling pressure might have exhausted for Theravance Bio (TBPH) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal. 0

https://www.zacks.com/stock/news/2207689/are-medical-stocks-lagging-adicet-bio-acet-this-year?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_1-2207689 Jan 09, 2024 - Here is how Adicet Bio, Inc. (ACET) and Aurora Cannabis Inc. (ACB) have performed compared to their sector so far this year. 0

https://seekingalpha.com/news/4053209-cabaletta-bio-gains-fda-fast-track-tags-lead-asset?source=feed_sector_healthcare Jan 08, 2024 - Cabaletta Bio's (CABA) stock rose after the FDA granted additional fast-track designations for its lead candidate in autoimmune conditions. Read more here. 0

https://seekingalpha.com/news/4051340-somalogic-board-urges-shareholders-to-approve-standard-bio-tools-merger?source=feed_sector_healthcare Dec 29, 2023 - SomaLogic’s (SLGC) board of directors has issued an open letter to stockholders urging them to vote for a proposed merger with Standard Bio Tools (LAB). Read more here. 0

https://www.zacks.com/stock/news/2203802/are-you-looking-for-a-top-momentum-pick-why-third-harmonic-bio-inc-thrd-is-a-great-choice?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_10-2203802 Dec 29, 2023 - Does Third Harmonic Bio, Inc. (THRD) have what it takes to be a top stock pick for momentum investors? Let's find out. 0

https://www.zacks.com/stock/news/2202282/senti-bio-snti-rises-as-fda-clears-ind-for-cancer-candidate?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2202282 Dec 26, 2023 - The FDA clears Senti Bio's (SNTI) investigational new drug application for SENTI-202 for the treatment of relapsed/refractory hematologic malignancies, including acute myeloid leukemia. Stock rises. 0